P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
P5.22: Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia ; volume:5 ; number:4 ; day:29 ; month:11 ; year:2011 ; pages:169 ; date:12.2011
Artery research ; 5, Heft 4 (29.11.2011), 169, 12.2011
- Classification
-
Medizin, Gesundheit
- Creator
-
Ershova, A. I.
Meshkov, A. N.
Rozhkova, T. A.
Rogoza, A. N.
Balakhonova, T. V.
Boytsov, S. A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1016/j.artres.2011.10.077
- URN
-
urn:nbn:de:101:1-2404291020488.615752934321
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ershova, A. I.
- Meshkov, A. N.
- Rozhkova, T. A.
- Rogoza, A. N.
- Balakhonova, T. V.
- Boytsov, S. A.
- SpringerLink (Online service)
Other Objects (12)
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
P76 Carotid Artery Disease in Patients with Newly Diagnosed, Untreated Familial Hypercholesterolemia
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
P76 Carotid Artery Disease in Patients with Newly Diagnosed, Untreated Familial Hypercholesterolemia
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
P76 Carotid Artery Disease in Patients with Newly Diagnosed, Untreated Familial Hypercholesterolemia
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study
Familial Hypercholesterolemia: new therapeutic approaches
Sex Differences in Familial Hypercholesterolemia
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia: Present and Future Management
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
Current causes of death in familial hypercholesterolemia
Familial hypercholesterolemia in very young myocardial infarction
Deploying Clinical Decision Support for Familial Hypercholesterolemia